70 results
Page 2 of 4
8-K
EX-1.1
0m8cnm v0zdvyfgib1
30 Oct 20
Entry into a Material Definitive Agreement
4:40pm
8-K
EX-1.1
8ufe86
4 May 20
Fennec Announces Proposed Public Offering of Common Shares
12:00am
424B5
64dxz6lxtqgd8xf2za7y
1 May 20
Prospectus supplement for primary offering
5:28pm
424B5
wsj abx10yrb37lep
29 Apr 20
Prospectus supplement for primary offering
4:48pm
8-K
EX-99.1
bwjsw6
28 Feb 20
Fennec Pharmaceuticals Receives European Medicines Agency Validation for Marketing Authorization Application for Sodium Thiosulfate
10:28am
8-K
EX-99.1
kqmikjhlg7u9m8q
11 Feb 20
PEDMARKTM1 is Being Developed for Prevention of Cisplatin-Induced Hearing Loss in Children
2:17pm
8-K
EX-99.1
qyqn1shbcjv
14 Mar 19
Fennec Provides Business Update and Announces Fiscal Year 2018 Financial Results
6:02am
8-K
EX-10.1
dh5b84
4 Feb 19
Fennec Pharmaceuticals Announces $12.5 Million Debt Financing with Bridge Bank
2:26pm